Cargando…

PB2399: BRENTUXIMAB VEDOTIN IN TREATING CHINESE PATIENTS WITH LYMPHOMA:A MULTICENTER,REAL-WORLD STUDY

Detalles Bibliográficos
Autores principales: Zhang, Xudong, Qiao, Honghan, Chai, Xiaofei, Gao, Xue, MA, Rongjun, LI, Yufu, Zhu, Zunmin, Zhang, Mingzhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428913/
http://dx.doi.org/10.1097/01.HS9.0000976308.74870.ea
_version_ 1785090584575213568
author Zhang, Xudong
Qiao, Honghan
Chai, Xiaofei
Gao, Xue
MA, Rongjun
LI, Yufu
Zhu, Zunmin
Zhang, Mingzhi
author_facet Zhang, Xudong
Qiao, Honghan
Chai, Xiaofei
Gao, Xue
MA, Rongjun
LI, Yufu
Zhu, Zunmin
Zhang, Mingzhi
author_sort Zhang, Xudong
collection PubMed
description
format Online
Article
Text
id pubmed-10428913
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104289132023-08-17 PB2399: BRENTUXIMAB VEDOTIN IN TREATING CHINESE PATIENTS WITH LYMPHOMA:A MULTICENTER,REAL-WORLD STUDY Zhang, Xudong Qiao, Honghan Chai, Xiaofei Gao, Xue MA, Rongjun LI, Yufu Zhu, Zunmin Zhang, Mingzhi Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428913/ http://dx.doi.org/10.1097/01.HS9.0000976308.74870.ea Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
Zhang, Xudong
Qiao, Honghan
Chai, Xiaofei
Gao, Xue
MA, Rongjun
LI, Yufu
Zhu, Zunmin
Zhang, Mingzhi
PB2399: BRENTUXIMAB VEDOTIN IN TREATING CHINESE PATIENTS WITH LYMPHOMA:A MULTICENTER,REAL-WORLD STUDY
title PB2399: BRENTUXIMAB VEDOTIN IN TREATING CHINESE PATIENTS WITH LYMPHOMA:A MULTICENTER,REAL-WORLD STUDY
title_full PB2399: BRENTUXIMAB VEDOTIN IN TREATING CHINESE PATIENTS WITH LYMPHOMA:A MULTICENTER,REAL-WORLD STUDY
title_fullStr PB2399: BRENTUXIMAB VEDOTIN IN TREATING CHINESE PATIENTS WITH LYMPHOMA:A MULTICENTER,REAL-WORLD STUDY
title_full_unstemmed PB2399: BRENTUXIMAB VEDOTIN IN TREATING CHINESE PATIENTS WITH LYMPHOMA:A MULTICENTER,REAL-WORLD STUDY
title_short PB2399: BRENTUXIMAB VEDOTIN IN TREATING CHINESE PATIENTS WITH LYMPHOMA:A MULTICENTER,REAL-WORLD STUDY
title_sort pb2399: brentuximab vedotin in treating chinese patients with lymphoma:a multicenter,real-world study
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428913/
http://dx.doi.org/10.1097/01.HS9.0000976308.74870.ea
work_keys_str_mv AT zhangxudong pb2399brentuximabvedotinintreatingchinesepatientswithlymphomaamulticenterrealworldstudy
AT qiaohonghan pb2399brentuximabvedotinintreatingchinesepatientswithlymphomaamulticenterrealworldstudy
AT chaixiaofei pb2399brentuximabvedotinintreatingchinesepatientswithlymphomaamulticenterrealworldstudy
AT gaoxue pb2399brentuximabvedotinintreatingchinesepatientswithlymphomaamulticenterrealworldstudy
AT marongjun pb2399brentuximabvedotinintreatingchinesepatientswithlymphomaamulticenterrealworldstudy
AT liyufu pb2399brentuximabvedotinintreatingchinesepatientswithlymphomaamulticenterrealworldstudy
AT zhuzunmin pb2399brentuximabvedotinintreatingchinesepatientswithlymphomaamulticenterrealworldstudy
AT zhangmingzhi pb2399brentuximabvedotinintreatingchinesepatientswithlymphomaamulticenterrealworldstudy